Linden Advisors’s Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share CLBR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-196,665
Closed -$151K 378
2025
Q1
$151K Sell
196,665
-20,000
-9% -$18.1K ﹤0.01% 236
2024
Q4
$327K Buy
+216,665
New +$177K ﹤0.01% 186

Other funds holding CLBR.WS

Linden Advisors's CLBR.WS Position: Q2 2025 in Review

Linden Advisors sold out of Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (CLBR.WS) in Q2 2025, closing a stake of 196,665 shares — an estimated $151K sold.

Linden Advisors first reported a position in CLBR.WS in Q4 2024 and held it in 2 quarters. The position peaked at $327K in Q4 2024. 15 funds tracked by Wall St. Rank hold CLBR.WS as of Q2 2025.

  • Linden Advisors reported no remaining Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q2 2025 after selling out during the quarter.
  • Linden Advisors sold 196,665 Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q2 2025, an estimated $151K.
  • Linden Advisors first reported a position in Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q4 2024 and held it in 2 quarters.
  • Linden Advisors's Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $327K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q2 2025.

Based on Linden Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.